Compare Nuvalent Inc (NUVL) vs US Bancorp (USB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvalent Inc vs US Bancorp — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while US Bancorp trades at $63.14 (market cap $98.36B). The key difference: US Bancorp is far larger — about 10× Nuvalent Inc's market cap, and US Bancorp pays a 3.29% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| NUVL | USB | |
|---|---|---|
Market Cap | $9.81B | $98.36B |
Sector | Technology | Financials |
52-Week High | $123.96 | $64.01 |
52-Week Low | $72.16 | $43.94 |
Enterprise Value | $8.52B | — |
Dividend Yield | — | 3.29% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →About US Bancorp
As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in well over 20 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.
Read more on USB →
